The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

Diabetes medication shortages are nothing new. The most recent example concerns NovoNordisk’s drug Ozempic, originally ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

Diabetes affects millions worldwide, often triggering complications such as insulin resistance and fatty liver disease. To ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

The drug has been approved to help treat type-2 diabetes, but a new study shows an increase in use in people with type-1 diabetes, and it may not be safe.

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient ...